Review decisions
Showing 1020 results of 2631 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00780
Product Type: Drug
Control Number: 237402
DIN(s): 02512912, 02512920
Manufacturer: Hoffmann-La Roche Ltd.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-03-20
Decision / Authorization Date: 2021-03-01
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00772
Product Type: Drug
Control Number: 244627
DIN(s): 02510847, 02511444
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Application filed under section 3 of the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19
Date Filed / Submission Date: 2020-10-01
Decision / Authorization Date: 2021-02-26
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00773
Product Type: Drug
Control Number: 248651
DIN(s): 02512947
Manufacturer: Verity Pharmaceuticals Inc.
Submission Type: Application filed under section 3 of the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19
Date Filed / Submission Date: 2021-01-23
Decision / Authorization Date: 2021-02-26
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00782
Product Type: Drug
Control Number: 230602
Manufacturer: Hoffmann-La Roche Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-08-09
Decision / Authorization Date: 2021-02-25
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00784
Product Type: Drug
Control Number: 237880
Manufacturer: Novo Nordisk Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-03-31
Decision / Authorization Date: 2021-02-25
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00537
Product Type: Drug
Control Number: 249830
DIN(s): 02516691, 02516705
Manufacturer: Hoffmann-La Roche Ltd.
Submission Type: Application for authorization under the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19
Date Filed / Submission Date: 2021-02-24
Issued / Original Publication Date: 2021-07-07
Decision / Authorization Date: 2021-06-09
Updated Date: 2024-09-20
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00777
Product Type: Drug
Control Number: 237081
Manufacturer: Sanofi-Aventis Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-03-17
Decision / Authorization Date: 2021-02-22
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00805
Product Type: Drug
Control Number: 237113
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-03-17
Decision / Authorization Date: 2021-02-22
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00601
Product Type: Drug
Control Number: 249774
DIN(s): 02526794, 02526808, 02526816, 02526824
Manufacturer: Allergan Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-02-22
Issued / Original Publication Date: 2022-08-26
Decision / Authorization Date: 2022-04-22
Updated Date: 2025-08-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00778
Product Type: Drug
Control Number: 236999
Manufacturer: Ipsen Biopharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-03-11
Decision / Authorization Date: 2021-02-19